tirzepatide mixed with glycine w/ and B12 is our most successful product for weight loss! combined, dual acting appetite suppressing properties, our patients have found the most success. This product will Preserving Muscle While Losing Fat:

This is more comfortable, creates smaller injection site bumps, and reduces the amount of preservative injected per dose

Safety and monitoring Before and during treatment you need baseline labs and periodic monitoring

Baseline Assessment (Before Starting Either Drug) Obtain serum creatinine, estimated GFR (eGFR), serum potassium, serum sodium, and a complete medication reconciliation

The FDA previously approved a related drug called Mounjaro, which is made from the same active ingredient in Zepbound: tirzepatide

Semaglutide Phase 3 Results# Semaglutide's weight loss data come from the much larger STEP program: In STEP 1, 86.4% achieved at least 5% weight loss, 69.1% achieved at least 10%, and 50.5% achieved at least 15%